Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes

Genes to Cells

Volumn 9, Issue 12, 2004, Pages 1265-1273

  Tsujimura, Shizuyo ^a   Saito, Kazuyoshi ^a   Nakayamada, Shingo ^a   Nakano, Kazuhisa ^a   Tsukada, Junichi ^a   Kohno, Kimitoshi ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOSPORIN A; DEXAMETHASONE; GLYCOPROTEIN P; INTERLEUKIN 2; MULTIDRUG RESISTANCE PROTEIN 1; TRANSCRIPTION FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; DRUG TARGETING; GENE ACTIVATION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; LYMPHOCYTE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CYCLOSPORINE; DEXAMETHASONE; DNA, ANTISENSE; DNA-BINDING PROTEINS; GENES, MDR; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; MONOCYTES; P-GLYCOPROTEIN; PROTEIN TRANSPORT; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

EID: 10244220988     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2004.00803.x     Document Type: Article

References (40)

1. Advani, R., Visani, G., Milligan, D., et al. (1999) Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC). Adv. Exp. Med. Biol. 457, 47-56.
2. Akahoshi, M., Nakashima, H., Tanaka, Y., et al. (1999) Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 42, 1644-1648.
3. Bargou, R.C., Jurchott, K., Wagener, C., et al. (1997) Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nature Med. 3, 447-450.
4. Beck, W.T., Grogan, T.M., Willman, C.L., et al. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res. 56, 3010-3020.
5. Bourgeois, S., Gruol, D.J., Newby, B.R.F. & Rajah, F.M. (1993) Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol. Endocrinol. 7, 840-851.
6. Burton, J.D., Bamford, R.N., Peters, C., et al. (1994) A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91, 4935-4939.
7. Chaudhary, P.M. & Roninson, I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66, 85-94.
8. Chaudhary, P.M. & Roninson, I.B. (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85, 632-639.
9. Dau, P.C., Callahan, J., Parker, R. & Golbus, J. (1991) Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus. J. Rheumatol. 18, 270-276.
10. Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian cell nuclei. Nucl. Acids Res. 11, 1475-1489.
11. Fedeli, L., Colozza, M., Boschetti, E., et al. (1989) Pharmacokinetics of vincristine in cancer patients treated with nifedipine. Cancer 64, 1805-1811.
12. Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M. & Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84, 265-269.
13. Hamada, H. & Tsuruo, T. (1986) Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 83 7785-7789.
14. Horwitz, D.A., Wang, H. & Gray, J.D. (1994) Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA. Lupus 3, 423-428.
15. Huang, Y.P., Perrin, L.H., Miescher, P.A. & Zubler, R.H. (1988) Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J. Immunol. 141, 827-833.
16. Itoh, H., Mukoyama, M., Pratt, R.E., Gibbons, G.H. & Dzau, V.J. (1993) Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91, 2268-2274.
17. Johannessen, I., Asghar, M. & Crawford, D.H. (2000) Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice. Br. J. Haematol. 109 600-610.
18. Kelly, E., Won, A., Refaeli, Y. & Van Parijs, L. (2002) IL-2 and related cytokines can promote T cell survival by activating AKT. J. Immunol. 168, 597-603.
19. Kohno, K., Sato, S., Takano, H., Matsuo, K. & Kuwano, M. (1989) The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Commun. 165, 1415-1421.
20. Linn, S.C., Honkoop, A.H., Hoekman, K., van der Valk, P., Pinedo, H.M. & Giaccone, G. (1996) p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br. J. Cancer 74, 63-68.
21. List, A.F., Kopecky, K.J., Willman, C.L., et al. (2002) Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. Blood 100, 1910-1912.
22. Luxembourg, A.T. & Cooper, N.R. (1994) T cell-dependent, B cell-activating properties of antibody-coated small latex beads. A new model for B cell activation. J. Immunol. 153, 604-614.
23. Miyazaki, M., Kohno, K., Uchiumi, T., et al. (1992) Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem. Biophys. Res. Commun. 187, 677-684.
24. Ohga, T., Koike, K., Ono, M., et al. (1996) Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 56, 4224-4422.
25. Ohga, T., Uchiumi, T., Makino, Y., et al. (1998) Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem. 273, 5997-6000.
26. Richard, C. & John, R.R. (1993) Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant ceEs. J. Biol. Chem. 268, 16059-16064.
27. Rodriguez-Viciana, P., Warne, P.H., Khwaja, A., et al. (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89, 457-467.
28. Stein, U., Walther, W. & Shoemaker, R.H. (1996) Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Br. J. Cancer 74, 1384-1391.
29. Sugawara, I., Kataoka, I., Morishita, Y., et al. (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res. 48, 1926-1929.
30. Tamada, M., Hu, C.D., Kariya, K., Okada, T. & Kataoka, T. (1997) Membrane recruitment of Raf-1 is not the only function of Ras in Raf-1 activation. Oncogene 15, 2959-2964.
31. Tanaka, Y., Kimata, K., Wake, A., et al. (1996) Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells. J. Exp. Med. 184, 1987-1997.
32. Tanaka, Y., Minami, Y., Mine, S., et al. (1999) H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells. J. Immunol. 163, 6209-6621.
33. Tanaka, Y., Saito, K., Shirakawa, F., et al. (1988) Production of B cell stimulating factors by B cells in patients with systemic lupus erythematosus. J. Immunol. 141, 3043-3049.
34. Tanaka, Y., Wake, A., Horgan, K.J., et al. (1997) Distinct phenotype of leukemic T cells with various tissue tropisms. J. Immunol. 158, 3822-3829.
35. Tanimura, H., Kohno, K., Sato, S., et al. (1992) The human multidrug resistance 1 promoter has an element that responds to serum starvation. Biochem. Biophys. Res. Commun. 183, 917-924.
36. Tsuruo, T (1983) Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics. Cancer Treat. Report 67 889-894.
37. Uchiumi, T., Kohno, K., Tanimura, H., et al. (1993a) Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth. Differ. 4, 147-157.
38. Uchiumi, T., Kohno, K., Tanimura, H., et al. (1993b) Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett. 326, 11-16.
39. Ueda, K., Cardaralli, C., Gottesman, M.M. & Pastan, I. (1987) Expression of a full length cDNA for the human 'MDR-1' gene confers resistance to colchicines, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 84, 3004-3008.
40. Zacherl, J., Hamilton, G., Thalhammer, T., et al. (1994) Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ. PSC 833 in dependence on extracellular pH. Cancer Chemother. Pharmacol. 34, 125-132.